SPN
Leukosialin
Also known as: CD43, GPL115, LEU-22, LEUK_HUMAN, LSN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P16150
- Gene
- SPN
- Ensembl
- ENSG00000197471
- Chromosome
- 16
- Canonical length
- 400 aa
- Protein class
- CD markers, Predicted membrane proteins
- Subcellular location
- Plasma membrane
OverviewNCBI Gene
This gene encodes a highly sialylated glycoprotein that functions in antigen-specific activation of T cells, and is found on the surface of thymocytes, T lymphocytes, monocytes, granulocytes, and some B lymphocytes. It contains a mucin-like extracellular domain, a transmembrane region and a carboxy-terminal intracellular region. The extracellular domain has a high proportion of serine and threonine residues, allowing extensive O-glycosylation, and has one potential N-glycosylation site, while the carboxy-terminal region has potential phosphorylation sites that may mediate transduction of activation signals. Different glycoforms of this protein have been described. In stimulated immune cells, proteolytic cleavage of the extracellular domain occurs in some cell types, releasing a soluble extracellular fragment. Defects in expression of this gene are associated with Wiskott-Aldrich syndrome. [provided by RefSeq, Sep 2017]
Canonical amino-acid sequenceUniProt
400 residues, UniProt reviewed canonical sequence.
>P16150|SPN
1 MATLLLLLGV LVVSPDALGS TTAVQTPTSG EPLVSTSEPL SSKMYTTSIT SDPKADSTGD
61 QTSALPPSTS INEGSPLWTS IGASTGSPLP EPTTYQEVSI KMSSVPQETP HATSHPAVPI
121 TANSLGSHTV TGGTITTNSP ETSSRTSGAP VTTAASSLET SRGTSGPPLT MATVSLETSK
181 GTSGPPVTMA TDSLETSTGT TGPPVTMTTG SLEPSSGASG PQVSSVKLST MMSPTTSTNA
241 STVPFRNPDE NSRGMLPVAV LVALLAVIVL VALLLLWRRR QKRRTGALVL SRGGKRNGVV
301 DAWAGPAQVP EEGAVTVTVG GSGGDKGSGF PDGEGSSRRP TLTTFFGRRK SRQGSLAMEE
361 LKSGSGPSLK GEEEPLVASE DGAVDAPAPD EPEGGDGAAPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SPN can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.71
- Highest tissue expression
- 68 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 68 nTPM
- thymus: 48 nTPM
- lung: 27 nTPM
- lymph node: 25 nTPM
- tonsil: 22 nTPM
- spleen: 18 nTPM
Single-cell type
- megakaryocyte progenitors: 9.8 nCPM
- megakaryocyte-erythroid progenitors: 7.3 nCPM
- erythrocyte progenitors: 5.8 nCPM
- thymocytes: 4.2 nCPM
- neutrophil progenitors: 2.7 nCPM
- nk-cells: 2.7 nCPM
Immune cell
- non-classical monocyte: 219 nTPM
- gdT-cell: 96 nTPM
- intermediate monocyte: 96 nTPM
- NK-cell: 69 nTPM
- memory CD8 T-cell: 65 nTPM
- total PBMC: 52 nTPM
Brain region
- white matter: 12 nTPM
- medulla oblongata: 11 nTPM
- thalamus: 8.9 nTPM
- pons: 8.4 nTPM
- spinal cord: 7.4 nTPM
- hypothalamus: 6.3 nTPM
ReferencesPubMed · IEDB
Publications for SPN from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
2 publications
- Human immunodeficiency virus type 1-infected individuals make autoantibodies that bind to CD43 on normal thymic lymphocytes.
1990 · J Exp Med · RCR 1.5 · 71 citations - Anti-CD43 and anti-galectin-1 autoantibodies in patients with systemic lupus erythematosus.
2010 · Scand J Rheumatol · RCR 0.5 · 16 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.94
- gnomAD pLI
- 0.01
- gnomAD missense Z
- -0.09
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic signaling pathway
- cell surface receptor signaling pathway
- cellular defense response
- chemotaxis
- defense response to bacterium
- establishment or maintenance of cell polarity
- immune response
- leukocyte tethering or rolling
- negative regulation of cell adhesion
- negative regulation of T cell proliferation
- negative regulation of type IV hypersensitivity
- negative thymic T cell selection
- positive regulation of T cell migration
- positive regulation of T cell proliferation
- positive regulation of tumor necrosis factor production
- regulation of defense response to virus
- regulation of immune response
- regulation of T cell migration
- response to protozoan
- signal transduction
- T cell costimulation
- T cell proliferation
- T-helper 1 cell lineage commitment
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Leukosialin
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SPN in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SPN as an antibody target. Whether an autoantibody or antibody against SPN could matter depends on whether native SPN is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SPN is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SPN as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...